pubmed-article:15806369 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C0007113 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C1704632 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C0871261 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C1517927 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C2911692 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C1706817 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C0024485 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C0032743 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C0681842 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C0814225 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C0600558 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C1517324 | lld:lifeskim |
pubmed-article:15806369 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
pubmed-article:15806369 | pubmed:issue | 8 | lld:pubmed |
pubmed-article:15806369 | pubmed:dateCreated | 2005-7-21 | lld:pubmed |
pubmed-article:15806369 | pubmed:abstractText | The aim of this study was to compare CT, MRI and FDG-PET in the prediction of outcome of neoadjuvant radiochemotherapy in patients with locally advanced primary rectal cancer. A total of 23 patients with T3/4 rectal cancer underwent a preoperative radiochemotherapy combined with regional hyperthermia. Staging was performed using four-slice CT (n=23), 1.5-T MRI (n=10), and (18)F-FDG-PET (n=23) before and 2-4 weeks after completion of neoadjuvant treatment. Response criteria were a change in T category and tumour volume for CT and MRI and a change in glucose uptake (standard uptake value) within the tumour for FDG-PET. Imaging results were compared with those of pretherapy endorectal ultrasound and histopathological findings. Histopathology showed a response to neoadjuvant therapy in 13 patients whereas 10 patients were classified as nonresponders. The mean SUV reduction in responders (60+/-14%) was significantly higher than in nonresponders (37+/-31%; P=0.030). The sensitivity and specificity of FDG-PET in identifying response was 100% (CT 54%, MRI 71%) and 60% (CT 80%, MRT 67%). Positive and negative predictive values were 77% (CT 78%, MRI 83%) and 100% (CT 57%, MRI 50%) (PET P=0.002, CT P=0.197, MRI P=0.500). These results suggest that FDG-PET is superior to CT and MRI in predicting response to preoperative multimodal treatment of locally advanced primary rectal cancer. | lld:pubmed |
pubmed-article:15806369 | pubmed:language | eng | lld:pubmed |
pubmed-article:15806369 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15806369 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15806369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15806369 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15806369 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15806369 | pubmed:month | Aug | lld:pubmed |
pubmed-article:15806369 | pubmed:issn | 0938-7994 | lld:pubmed |
pubmed-article:15806369 | pubmed:author | pubmed-author:FelixRR | lld:pubmed |
pubmed-article:15806369 | pubmed:author | pubmed-author:RaoDD | lld:pubmed |
pubmed-article:15806369 | pubmed:author | pubmed-author:RufJJ | lld:pubmed |
pubmed-article:15806369 | pubmed:author | pubmed-author:WustPP | lld:pubmed |
pubmed-article:15806369 | pubmed:author | pubmed-author:HünerbeinMM | lld:pubmed |
pubmed-article:15806369 | pubmed:author | pubmed-author:HildebrandtBB | lld:pubmed |
pubmed-article:15806369 | pubmed:author | pubmed-author:AmthauerHH | lld:pubmed |
pubmed-article:15806369 | pubmed:author | pubmed-author:DeneckeTT | lld:pubmed |
pubmed-article:15806369 | pubmed:author | pubmed-author:GutberletMM | lld:pubmed |
pubmed-article:15806369 | pubmed:author | pubmed-author:HoffmannK-TKT | lld:pubmed |
pubmed-article:15806369 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:15806369 | pubmed:volume | 15 | lld:pubmed |
pubmed-article:15806369 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15806369 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15806369 | pubmed:pagination | 1658-66 | lld:pubmed |
pubmed-article:15806369 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:meshHeading | pubmed-meshheading:15806369... | lld:pubmed |
pubmed-article:15806369 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15806369 | pubmed:articleTitle | Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: is there a benefit in using functional imaging? | lld:pubmed |
pubmed-article:15806369 | pubmed:affiliation | Klinik für Strahlenheilkunde und PET-Zentrum Berlin Campus Virchow Klinikum, Charité-Universitätsmedizin Berlin, Augustenburger Platz 1, Berlin, 13353, Germany. timm.denecke@charite.de | lld:pubmed |
pubmed-article:15806369 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15806369 | pubmed:publicationType | Comparative Study | lld:pubmed |
pubmed-article:15806369 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
pubmed-article:15806369 | pubmed:publicationType | Clinical Trial, Phase III | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15806369 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15806369 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15806369 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15806369 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15806369 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15806369 | lld:pubmed |